Stanford University: Brain Neoplasms trials

The registry lists 12 Brain Neoplasms studies with Stanford University as lead sponsor. 4 are open to participants now and 2 have results posted.

Phase 1 6Phase 2 4No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young AdultsRecruitingNCT07087002Phase 1
• Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain MetastasesRecruitingNCT06712927Phase 2
• Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical ProceduresRecruitingNCT04085887Phase 1/2
• Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing SurgeryRecruitingNCT03510208Phase 1/2
• Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma MultiformCompletedNCT01120639Phase 1/2Results posted
• Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain MetastasesCompletedNCT00928226Not applicableResults posted
• CONVIVO System to Discriminate Healthy Tissues vs Tumor Tissues During Brain Tumor ResectionWithdrawnNCT05247749Not applicable
• Phase I Compare OS in Post-CyberKnife Radiosurgery Tx in 1-3 VS 4 or More Brain MetastasesWithdrawnNCT01778764
• Molecular Genetic Studies of Childhood Brain Tumors and Blood SamplesCompletedNCT01650922
• Consent for Obtaining Additional Bone Marrow Specimens at Time of Diagnostic Bone Marrow ProcedureTerminatedNCT01048060
• Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung CancerCompletedNCT00946673Phase 1
• Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant GliomaCompletedNCT00185861Phase 1